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Abstract
Background: Atrioventricular reentrant tachycardia (AVRT) in patients with preexcitation
syndrome (PS) is the main cause of paroxysmal regular arrhythmias in children and adoles-
cents. While the previously published data most commonly concern clinical consequences of PS
in adults, few researchers have evaluated the problem in children and adolescents. The aim of
the study was to compare the clinical course of PS between the population of children and
adolescents below 19 years of age and the population of adult patients.
Method: The study population consisted of 302 consecutive PS patients managed between Janu-
ary 2001 and June 2005 with radiofrequency catheter ablation (RFCA). The study population was
divided into two groups: Group 1 consisting of 52 patients aged 15.38 years on average (7–18 ±
± 2.53) and Group 2 consisting of 250 adult patients aged 38.67 years on average (19–72 ± 13.1).
Results: Patients from Groups 1 and 2 experienced their first episode of AVRT at the mean
age of 13.3 years and 29.1 years, respectively (p < 0.05). The mean annual numbers of AVRT
episodes in Groups 1 and 2 were 12.97 (range, 2–96; median, 8) and 8.86 (range, 2–25;
median, 6), respectively (p = non-significant). Two patients from Group 1 (3.85%) and
42 patients from Group 2 (16.8%) experienced episodes of atrial fibrillation (AF) (p < 0.05).
Location of the accessory pathways (AP): In Group 1, the right free wall and anteroseptal AP
locations were significantly more common [11 (21.15%) and 9 (17.31%) patients, respectively,
vs. 19 (7.6%) and 13 (5.2%) patients in Group 2; p < 0.01]. In Group 2, the left anterolateral
AP location was more common [81 (32.4%) vs. 4 (7.69%) in Group 1; p < 0.01].
Conclusions: In children and adolescents with PS, a significantly lower incidence of AF was
found. In Group 1, RFCA was performed significantly more frequently due to the development
of AVRT caused by right free wall and right anteroseptal AP, while in the group of adults, the
left anterolateral AP location was found more commonly. (Cardiol J 2007; 14: 384–390)
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acceptable representatives had been informed of the
aims, methodology and the possible complications
of the procedure and after informed consent had
been obtained. The study population was divided
into two groups: Group 1 consisting of 52 patients
less than 19 years of age and Group 2 consisting of
250 adult patients.
A retrospective analysis of the following param-
eters describing the course of the disease were
evaluated: duration of symptoms in the form of par-
oxysmal tachyarrhythmias, annual frequency of
tachycardia episodes, presence of clinically docu-
mented episodes of atrial fibrillation (AF) or flutter
and syncopes, and a history of episodes of cardiac
arrest. A comparative analysis of locations of the ac-
cessory pathways was also performed.
We used the classification of accessory path-
ways developed by Josephson, who distinguished
the following AP locations: right free wall (RFW),
right anteroseptal (RAS), right mid-septal (RMS),
right posteroseptal (RPS), left posteroseptal (LPS),
left posterolateral (LPL) and left anterolateral
(LAL) [3]. In addition, pathways which end in the
coronary sinus were distinguished (CS).
Subjects in whom the presence of more than
one accessory pathway was discovered were clas-
sified to all AP location groups. Example: a pa-
tient with two accessory pathways, left postero-
septal and left posterolateral was included in two
groups of AP location: LPS and LPL. Hence the
number of AP in Table 1 is higher than the
number of subjects.
Statistical analysis
The comparative analysis of continuous varia-
bles between the groups was performed using the
t-Student test for unpaired data. The significance
of the differences for qualitative variables was test-
ed using the non-parametric c2 test with Yates’ cor-
rection for small sample sizes.
Introduction
Atrioventricular reentrant tachycardia (AVRT)
with an involvement of an accessory pathway (AP)
in patients with preexcitation syndrome (PS) is the
main cause of reentrant arrhythmias in children and
adolescents with structurally healthy hearts.
The formation of the accessory connection is
a consequence of abnormal development of the
fibrous rings in the heart, which form the anatomic
and electric barrier that separates the atria from the
ventricles. Developmental anomalies in the embry-
onic period make it possible for atrial fibres to pen-
etrate the ventricular myocardium. The annual
prevalence of PS is 4 per 100,000 persons and it is
estimated that electrocardiographic signs of preex-
citation may be found in 0.1–0.3% of the general
population. In the population of children, the inci-
dence of PS is estimated at approximately 0.1% [1].
The clinical picture of PS may vary from asymp-
tomatic to life-threatening secondary tachyarrhyth-
mias. While the published data most commonly con-
cern clinical consequences of PS in adults, few re-
searchers have evaluated this problem in children
and adolescents [2].
The aim of the study was to compare the clin-
ical course of PS between the population of children
and adolescents below 19 years of age and the pop-
ulation of adult patients.
Method
The study population consisted of 302 consec-
utive symptomatic patients with drug-resistant PS
without a structural heart disease, managed be-
tween January 2001 and June 2005. All the patients
underwent the invasive electrophysiologic study
(EPS) and radiofrequency catheter ablation (RFCA).
The study was conducted after the patient or, in the
case of children, the patient’s parents or legally
Table 1. Comparative analysis of the clinical course of preexcitation syndrome.
Group 1 Group 2 P value
Mean age (SD) at onset of symptoms 13.33 (1.73) 29.12 (12.27) < 0.001
Annual number of atrioventricular 12.97 ±16.5 (2–96) 8.86 ± 8.07 (2–52) NS
reentrant tachycardia episodes median 8 median 6
Cardiac arrest 1 (1.92%) 5 (2.0%) NS
MAS 0 7 (2.8%) NS
Atrial fibrillation 2 (3.85%) 42 (16.8%) < 0.05
Atrial flutter 0 9 (3.6%) NS
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a history of MAS episodes in Group 2 (p = non-sig-
nificant). In group 1, significantly fewer patients had
experienced documented clinical episodes of AF
[2 (3.85%) vs. 42 (16.8%), p < 0.05]. There were
no documented cases of atrial flutter in Group 1, while
9 patients (3.6%) from Group 2 had experienced epi-
sodes of atrial flutter (p = non-significant) (Table 1).
Location of the accessory pathway
In Group 1, the right free wall and anterosep-
tal AP locations were significantly more common
[11 (21.15%) and 9 (17.31%) patients, respective-
ly, vs. 19 (7.6%) and 13 (5.2%) patients in Group 2;
p < 0.01], while in Group 2, the most common AP
location was left anterolateral [81 (32.4%) vs. 4
(7.69%) in Group 1, p < 0.01]. The distribution of
the other AP locations, including the occurrence of
multiple APs was similar in both groups of patients
(Table 3).
Discussion
Paroxysmal regular tachycardias with narrow
QRS complexes are the most common tachy-
arrhythmias in children and adolescents with
Results
Demographic and clinical characteristics of
both groups
Group 1 consisted of 52 patients aged 15.38
years on average, in whom electrophysiologic stud-
ies revealed signs of preexcitation and/or AVRT was
induced. The adult group consisted of 250 patients
aged 38.67 years on average. In Group 2, ischem-
ic heart disease was present in 10 patients (4%),
hypertension in 30 (12%) and type 2 diabetes in
1 (0.4%); 4 patients (1.6%) had a history of myo-
cardial infarction (Table 2).
In the group of children and adolescents, the
mean age at first episode of tachycardia was 13.3
years and was significantly lower than in the group
of adults (29.1 years, p < 0.05). The mean annual
numbers of AVRT episodes in Groups 1 and 2 were
12.97 (range, 2–96; median, 8) and 8.86 (range, 2–25;
median, 6), respectively (p = non-significant). One
patient (1.92%) from Group 1 and 5 (2.0%) from
Group 2 had suffered an episode of cardiac arrest
(p = non-significant). Analysis of the history of syn-
cope episodes revealed no patients with a history
of MAS episodes in Group 1 and 7 patients (2.8%)
Table 3. Comparative analysis of the accessory pathway locations.
Accessory pathway location Group 1 Group 2 P value
Right free wall 11 (21.15%) 19 (7.60%) < 0.01
Right anteroseptal 9 (17.31%) 13 (5.20%) < 0.01
Right mid-septal 3 (5.77%) 28 (11.20%) NS
Right posteroseptal 8 (15.38%) 28 (11.20%) NS
Coronary sinus 2 (3.85%) 26 (10.40%) NS
Left posteroseptal 4 (7.69%) 20 (8.0%) NS
Left posterolateral 13 (25.0%) 54 (21.60%) NS
Left anterolateral 4 (7.69%) 81 (32.40%) < 0.01
MAP 2 (3.85%) 20 (8.0%) NS
AP ERP [ms] mean ±SD/range 246.88 ± 9.46/230–260 253.81 ± 13.37/230–280 NS
AP ERP — accessory pathway effective refraction period
Table 2. Demographic and clinical characteristics of both study groups.
Group 1 Group 2 P value
Number of patients 52 250 NS
Sex (female) 24 (46.15%) 115 (46%) NS
Mean age (SD)/range [years] 15.38 (2.53)/7–18 38.67 (13.1)/19–72 < 0.05
Mean LVEDD (SD)/range [mm] 45.69 (5.05)/39–54 48.83 (6.24)/35–67 NS
Mean LVESD (SD)/range [mm] 29.23 (4.58)/23–38 30.63 (5.06)/22–44 NS
Mean LVEF (SD)/range (%) 64.92 (4.42)/60–72 55.58 (6.52)/35–75 NS
LVEDD — left ventricular end-diastolic dimension in the parasternal view, M mode; LVESD — left ventricular end-systolic dimension; LVEF — left
ventricular ejection fraction in the apical four-chamber view
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structurally healthy hearts. In this age group,
approximately 70% of the diagnosed cases were
caused by atrioventricular reentrant tachycardia due
to the presence of an accessory pathway [2]. The
course of the disease in children and adults can vary
and ranges from asymptomatic to life-threatening
secondary tachyarrhythmias. Assessment of the
risk of adverse consequences of preexcitation syn-
drome in children is therefore essential to the se-
lection of treatment.
Medical history of the children and adolescents
we studied revealed a higher incidence of AVRT
episodes than in the group of adult subjects. The
mean number of episodes was approximately 13 and
9 in Groups 1 and 2, respectively, although the dif-
ference was not statistically significant. One should,
however, bear it in mind that the assessment fo-
cused on the year preceding RFCA only. Document-
ed episodes of atrial fibrillation were, however, ex-
perienced by a significantly lower number of pa-
tients in Group 1 versus Group 2 (3.85% vs. 16.8%).
In the literature, the role of the mere presence
of an accessory pathway in the induction of parox-
ysmal atrial fibrillation is emphasised. Some pa-
tients are suspected to have heterogenous and bi-
furcated ends of the AP, which allows for the gen-
eration of microreentry waves as a result of changes
in electrophysiologic parameters in this area [4].
Arguments to the contrary are provided by Fujimu-
ra et al. [5], who found that atrial fibrillation was in-
itiated by rapid atrial tachycardia which started at
a high right atrial site and generated into the AF with-
in 10 to 20 cycles. There are also reports which em-
phasise adrenergic predominance and reduced par-
asympathetic activity in patients with AF and pre-
excitation syndrome, which may result in shorter
AP refraction periods and shorter cycle of tachycar-
dia [6]. In a postmortem study of patients with doc-
umented preexcitation syndrome who had died of
sudden cardiac death (SCD), Basso et al. [7] found
local inflammation in the atria in 50% of the sub-
jects, which could have been the source of rapid
electric activity. There are also reports of effects
of temporal sequence of ventricular and atrial acti-
vation during AVRT, which may increase atrial
pressures [8]. In numerous publications, the prev-
alence of AF in adults with preexcitation syndrome
is estimated at over 30%, while there are few re-
ports on children with PS [9–11]. In the general
population of children and adolescents with struc-
turally healthy hearts, AF is extremely rare. Idio-
pathic AF may develop during pubescence. The
presence of an ectopic focus in the pulmonary veins,
the crista terminalis or the left atrium is the report-
ed mechanism of induction and maintenance of AF
in children and adults without an accessory path-
way [1, 12, 13]. Fan et al. [14] found AF during EPS
more frequently in patients over 50 years of age
than in patients below 30 years of age. The mecha-
nism of this phenomenon is unclear. It may result
from the fact that in the general population, the fre-
quency of AF episodes increases with age and
changes caused by the presence of an accessory
pathway and tachycardia are augmented by degen-
erative changes causing dispersion of the refraction
periods in the atrial myocardium [11]. Lee et al. [15]
induced AF during rapid atrial stimulation in 22%
of children with preexcitation syndrome, in whom
a significantly shorter atrial effective refraction pe-
riod was found than in the group of children with
AVRT without atrial fibrillation.
In the population of adults with preexcitation
syndrome, episodes of AF with rapid ventricular
response and syncope are regarded as risk factors
for SCD, while the risk of SCD in children with the
disorder remains unclear [9, 10, 16]. Bromberg et
al. [17] investigated 60 patients below 19 years of
age with symptomatic WPW syndrome and distin-
guished three SCD risk groups: high-risk patients
with a history of ventricular fibrillation or asystole
episode, intermediate-risk patients with a history
of AF and syncope and low-risk patients with reen-
trant tachycardia being the only documented ar-
rhythmia. When RR intervals during induced AF
were analysed, values below 220 ms were found in
all the patients from the first group, in 74% of the
patients in the second group and only in 35% of the
patients in the third group.
No statistically significant differences in the
accessory pathway effective refraction periods be-
tween the three groups were found. The groups did
not differ in terms of age, duration of symptoms or
coexistence of congenital heart disease [17]. The
predictive value of a short RR interval in the assess-
ment of risk for SCD has also been confirmed in
studies of adult populations [9, 16].
In a population of children with PS, Dubin et
al. [18] compared asymptomatic patients with
a group with documented reentrant tachycardias
and with patients with a history of syncope epi-
sodes. Having analysed the risk factors for SCD that
are well established for the adult population (acces-
sory pathway effective refraction < 270 ms, pres-
ence of multiple or septal pathways and the possi-
bility of AVRT stimulation), he found no significant
differences between the groups.
Few publications indicate that cardiac arrest
in the course of AF may be the first manifestation
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of preexcitation syndrome, also in the pediatric
population [19]. While it seems obvious that chil-
dren with symptomatic PS, especially drug-resist-
ant, should undergo invasive treatment, no consen-
sus has been reached as to the management of
patients in whom electrocardiographic signs of pre-
excitation are the only manifestation of the dis-
ease. Pappone performed a Holter study in a pop-
ulation of 27 asymptomatic children with overt pre-
excitation syndrome 12 years of age or younger,
in whom AVRT or AF were induced during elec-
trophysiologic study.
In this group, episodes of asymptomatic AF
with rapid ventricular response were induced in
5 children, while ventricular fibrillation was in-
duced in another two. One patient died a sudden
death. In the control group of 105 patients, in
whom no reentrant tachycardia or AF could be in-
duced during electrophysiologic study, sympto-
matic episodes of reentrant tachycardia were re-
corded in 6 patients, while AF was recorded in
2 patients [20]. Sarubbi et al. [21] performed an
invasive electrophysiologic study. In 36 of 62
(58.1%) asymptomatic patients with preexcitation
syndrome aged 9.8 ± 5.1 years on average, epi-
sodes of supraventricular tachycardia were stim-
ulated, nine of which were episodes of atrial fi-
brillation. According to the above studies, chil-
dren with signs of preexcitation on standard
electrocardiogram as the only manifestation of the
disease are also at risk of sudden cardiac death.
In a survey conducted by Campbell et al. [22],
most electrophysiologists confirmed that they
would perform electrophysiologic study and
RFCA in asymptomatic children with overt PS.
One should also consider the fact that even very
rapid tachyarrhythmias in children with structur-
ally healthy hearts may be oligosymptomatic and
that history taking and evaluation of clinical symp-
toms, especially in younger children, are difficult.
Evaluation of the accessory pathway location
in both age groups revealed a significantly higher
percentage of right-sided locations (RFW and RAS)
and a lower percentage of left anterolateral location
in children versus adults. The most likely reason
may be the earlier manifestation of tachyarrhyth-
mias dependent on the right-sided location of the
accessory pathway.
Fan et al. [14] compared a group below 30 years
of age with a group over 50 years of age in terms of
the clinical course and found a higher percentage
of right lateral accessory pathways in the younger
group (14% vs. 2%). Tada et al. [23] analysed
910 patients with preexcitation syndrome and found
a statistically significant younger age of onset of
symptoms in the form paroxysmal tachycardias in
patients with right-sided versus left-sided locations
of AP (21 ± 12 years vs. 23 ± 15 years). Factors
contributing to the earlier manifestation of tachyar-
rhythmias dependent on the right-sided accessory
pathways have not been completely elucidated. The
most common mechanism that initiates tachycar-
dia in preexcitation syndrome is atrial premature
beat arising in close vicinity of the atrial end of the
accessory pathway. Hence the greater tendency of
the right atrium to generating premature beats may
result in the earlier manifestation of reentrant atri-
oventricular arrhythmias dependent on right-sided
pathways. Another condition for the maintenance
of tachycardia includes an appropriate relationship
of refraction periods and conduction velocity be-
tween the accessory pathway, atrioventricular junc-
tion and atrial and ventricular myocardium [14].
Liu et al. [24] observed a longer RR interval with
right-sided versus left-sided and septal AP locations
in patients with preexcitation syndrome. In addition,
in the group of patients with a right-sided accesso-
ry pathway, they found first degree atrioventricu-
lar block with a PR of > 220 ms. The prolongation
of conduction through the His-Purkinje system may
offer sufficiently long time to end the refraction
period in the accessory pathway and to develop
a reentry loop. Contrasting results were obtained
by Perry and Garson [25] in a population of 140 chil-
dren, they found no differences in the clinical course
of the disease that would depend on the accessory
pathway location, including the age of onset of
AVRT. In our population, during electrophysiolog-
ic study of patients below 19 years of age, AP re-
fraction period was assessed in 25 patients (48.08%)
versus 134 adult patients (53.6%). The values did
not differ significantly between the groups. The
mean retrograde effective refraction period of the
AP was 246.88 ms in Group 1 and 253.81 ms in
Group 2. Evaluation of refraction periods in Group
1 is most probably inadequate due to the fact that
in the majority of patients, the procedure was per-
formed under general anesthesia.
In Group 1, we found multiple accessory path-
ways in 2 patients (3.85%), which was not significant
in comparison to the 8% of MAP in the adult popula-
tion. In published studies, the frequency of multiple
pathways is estimated at 3–22% [26]. The slightly
lower frequency of more than one AP in Group 1 in
our study may result from the exclusion of patients
with structural heart anomalies. Weng et al. [27]
found multiple (2 to 4) accessory pathways in 28 of
317 children with preexcitation syndrome. In this
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group, they noted a higher percentage of patients
with a coexistent structural heart disease (Ebstein
syndrome — 3, L-transposition of large vessels — 1,
hypertrophic cardiomyopathy — 1).
Clinical implications
In children and adolescents with preexcitation
syndrome, a significantly lower incidence of danger-
ous complications in the form of atrial fibrillation
was found compared to adults.
In the younger group, RFCA was performed
significantly more frequently due to the develop-
ment of AVRT caused by right free wall and right
anteroseptal accessory pathways, while in the group
of adults, the left anterolateral accessory pathway
location was found more commonly.
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